Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial
Catharina J.M. Klijn(University Medical Center Utrecht), Gabriël J.E. Rinkel(Utrecht University), Koen M. van Nieuwenhuizen(University Medical Center Utrecht), Ale Algra(University Medical Center Utrecht), Roger E. G. Schutgens(Utrecht University), L. Jaap Kappelle(SUNY Downstate Health Sciences University), Isabelle C. Van Gelder(University Medical Center Groningen), H. Bart van der Worp(University Medical Center Utrecht)
Cited by 66
Related Papers
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.
|Stroke|1993|12.3k
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
|European Heart Journal|2024|2.4k
Subclinical Atrial Fibrillation and the Risk of Stroke
|New England Journal of Medicine|2012|2.1k